Tsikopoulos Alexios, Tsikopoulos Konstantinos, Dilmperis Fotios, Anastasiadou Sofia, Garefis Konstantinos, Fountarlis Athanasios, Triaridis Stefanos
1st Department of Otorhinolaryngology-Head and Neck Surgery, AHEPA University General Hospital, Aristotle University of Thessaloniki, Kiriakidi 1, Thessaloniki, 546 21 Greece.
Department of Orthopedics, 424 Army General Training Hospital, Thessaloniki, Greece.
Indian J Otolaryngol Head Neck Surg. 2024 Oct;76(5):4910-4922. doi: 10.1007/s12070-024-04738-0. Epub 2024 May 20.
The treatment of children with Obstructive Sleep Apnea Syndrome (OSAS) remains a point of debate among otorhinolaryngologists worldwide. This study aims to comparatively assess the clinical outcomes of adenotonsillectomy (ATE) and watchful waiting in children with OSAS. We searched the databases of PubMed, Scopus, and Cochrane Central Register of Controlled Trials (CENTRAL), until the 1st of October 2023. Comparative trials assessing the efficacy of adenotonsillectomy and watchful waiting in children with OSAS were considered. The primary outcome measure was the apnea-hypopnea index (AHI), and secondary outcomes included quality of life as measured by OSA-18 score, and mean SpO2 levels. A subgroup analysis evaluating the changes in AHI depending on the severity of the initial disease was also executed. We conducted a random-effects pairwise meta-analysis of change scores to include randomized and non-randomized controlled trials. The quality assessment was carried out by using the Cochrane risk of bias tool for randomized and the ROBINS-I tool for non-randomized trials, respectively. Two randomized and five non-randomized trials were included. There was a statistically significant difference regarding AHI in favor of the ATE group compared to the watchful waiting group (Standardized mean difference [SMD] was - 0.60, 95%CI -0.79 to -0.41, < 0.001). Likewise, a statistically significant decrease in change scores for OSA-18 between ATE and watchful waiting was noted (SMD was - 0.79, 95%CI -0.97 to -0.61, < 0.001). On the other hand, there was no significant difference when ATE and watchful waiting groups were compared for SpO2 levels between each other (SMD was 0.52, 95%CI -1.53 to 2.56, < 0.62). In the subgroup analysis assessing mild OSAS, there was a significant difference in favor of ATE compared to watchful waiting (SMD was -0.91, 95%CI -1.35 to -0.47, < 0.0001). For mild to moderate OSAS, similar results were noted favoring ATE as well (SMD was - 0.53, 95%CI -0.87 to -0.19, < 0.003). This study provides evidence of moderate strength supporting the superiority of ATE over the watchful waiting approach in terms of AHI and OSA-18. This also appears to be the case for AHI in children with mild and mild to moderate OSAS.
The online version contains supplementary material available at 10.1007/s12070-024-04738-0.
阻塞性睡眠呼吸暂停低通气综合征(OSAS)患儿的治疗仍是全球耳鼻喉科医生争论的焦点。本研究旨在比较评估腺样体扁桃体切除术(ATE)与对OSAS患儿进行观察等待的临床效果。我们检索了PubMed、Scopus和Cochrane对照试验中心注册库(CENTRAL)的数据库,直至2023年10月1日。纳入评估腺样体扁桃体切除术和观察等待对OSAS患儿疗效的比较试验。主要结局指标为呼吸暂停低通气指数(AHI),次要结局包括用OSA - 18评分衡量的生活质量和平均血氧饱和度(SpO2)水平。还进行了一项亚组分析,评估AHI根据初始疾病严重程度的变化情况。我们对变化分数进行随机效应成对荟萃分析,纳入随机对照试验和非随机对照试验。分别使用Cochrane随机偏倚风险工具和ROBIN - I工具对随机试验和非随机试验进行质量评估。纳入两项随机试验和五项非随机试验。与观察等待组相比,ATE组在AHI方面存在统计学显著差异(标准化均差[SMD]为 -0.60,95%置信区间 -0.79至 -0.41,<0.001)。同样,注意到ATE组和观察等待组之间OSA - 18变化分数有统计学显著降低(SMD为 -0.79,95%置信区间 -0.97至 -0.61,<0.001)。另一方面,比较ATE组和观察等待组的SpO2水平时,二者之间无显著差异(SMD为0.52,95%置信区间 -1.53至2.56,<0.62)。在评估轻度OSAS的亚组分析中,与观察等待相比,ATE组有显著差异(SMD为 -0.91,95%置信区间 -1.35至 -0.47,<0.0001)。对于轻度至中度OSAS,也注意到类似结果支持ATE组(SMD为 -0.53,95%置信区间 -0.87至 -0.19,<0.003)。本研究提供了中等强度的证据,支持在AHI和OSA - 18方面,ATE优于观察等待方法。对于轻度和轻度至中度OSAS患儿的AHI情况似乎也是如此。
在线版本包含可在10.1007/s12070 - 024 - 04738 - 0获取的补充材料。